Targeting KPNB1 overcomes TRAIL resistance by regulating DR5, Mcl-1 and FLIP in glioblastoma cells
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2041-4889
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Targeting KPNB1 overcomes TRAIL resistance by regulating DR5, Mcl-1 and FLIP in glioblastoma cells ; volume:10 ; number:2 ; day:11 ; month:2 ; year:2019 ; pages:1-16 ; date:2.2019
Cell death & disease ; 10, Heft 2 (11.2.2019), 1-16, 2.2019
- Creator
-
Zhu, Zhi-Chuan
Liu, Ji-Wei
Yang, Can
Li, Ming-Jie
Wu, Rong-Jie
Xiong, Zhi-Qi
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41419-019-1383-x
- URN
-
urn:nbn:de:101:1-2019031320013907553088
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:48 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Zhu, Zhi-Chuan
- Liu, Ji-Wei
- Yang, Can
- Li, Ming-Jie
- Wu, Rong-Jie
- Xiong, Zhi-Qi
- SpringerLink (Online service)
Other Objects (12)
Silencing of Mcl-1 overcomes resistance of melanoma cells against TRAIL-armed oncolytic adenovirus by enhancement of apoptosis
Silencing of Mcl-1 overcomes resistance of melanoma cells against TRAIL-armed oncolytic adenovirus by enhancement of apoptosis
Stress-induced TRAILR2 expression overcomes TRAIL resistance in cancer cell spheroids
Choline kinase alpha impairment overcomes TRAIL resistance in ovarian cancer cells
MET inhibition overcomes radiation resistance of glioblastoma stem‐like cells
HuR inhibition overcomes cFLIP-mediated doxorubicin resistance in triple-negative breast cancer
MCL.
Mcl‐1 targeting strategies unlock the proapoptotic potential of TRAIL in melanoma cells
Guiding TRAIL to cancer cells through Kv10.1 potassium channel overcomes resistance to doxorubicin
Coordinated autophagy modulation overcomes glioblastoma chemoresistance through disruption of mitochondrial bioenergetics
MCL-1 inhibition overcomes anti-apoptotic adaptation to targeted therapies in B-cell precursor acute Lymphoblastic Leukemia
MUC16 mucin (CA125) attenuates TRAIL-induced apoptosis by decreasing TRAIL receptor R2 expression and increasing c-FLIP expression
Silencing of Mcl-1 overcomes resistance of melanoma cells against TRAIL-armed oncolytic adenovirus by enhancement of apoptosis
Silencing of Mcl-1 overcomes resistance of melanoma cells against TRAIL-armed oncolytic adenovirus by enhancement of apoptosis
Stress-induced TRAILR2 expression overcomes TRAIL resistance in cancer cell spheroids
Choline kinase alpha impairment overcomes TRAIL resistance in ovarian cancer cells
MET inhibition overcomes radiation resistance of glioblastoma stem‐like cells
HuR inhibition overcomes cFLIP-mediated doxorubicin resistance in triple-negative breast cancer
MCL.
Mcl‐1 targeting strategies unlock the proapoptotic potential of TRAIL in melanoma cells
Guiding TRAIL to cancer cells through Kv10.1 potassium channel overcomes resistance to doxorubicin
Coordinated autophagy modulation overcomes glioblastoma chemoresistance through disruption of mitochondrial bioenergetics
MCL-1 inhibition overcomes anti-apoptotic adaptation to targeted therapies in B-cell precursor acute Lymphoblastic Leukemia
MUC16 mucin (CA125) attenuates TRAIL-induced apoptosis by decreasing TRAIL receptor R2 expression and increasing c-FLIP expression
Silencing of Mcl-1 overcomes resistance of melanoma cells against TRAIL-armed oncolytic adenovirus by enhancement of apoptosis
Silencing of Mcl-1 overcomes resistance of melanoma cells against TRAIL-armed oncolytic adenovirus by enhancement of apoptosis
Stress-induced TRAILR2 expression overcomes TRAIL resistance in cancer cell spheroids
Choline kinase alpha impairment overcomes TRAIL resistance in ovarian cancer cells
MET inhibition overcomes radiation resistance of glioblastoma stem‐like cells
HuR inhibition overcomes cFLIP-mediated doxorubicin resistance in triple-negative breast cancer
MCL.
Mcl‐1 targeting strategies unlock the proapoptotic potential of TRAIL in melanoma cells
Guiding TRAIL to cancer cells through Kv10.1 potassium channel overcomes resistance to doxorubicin
Coordinated autophagy modulation overcomes glioblastoma chemoresistance through disruption of mitochondrial bioenergetics
MCL-1 inhibition overcomes anti-apoptotic adaptation to targeted therapies in B-cell precursor acute Lymphoblastic Leukemia